ORGO Organogenesis Holdings Inc.
Nasdaq · SEC CIK 1661181 · EDGAR
- Bought, last 12 months
- $40.1K 2 purchases by 2 insiders
- Sold, last 12 months
- $2.62M 2 sales by 1 insiders
- Filings on record
- 174 since 2021-07-20, latest 2026-04-24 21:29
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| NUSSDORF GLENN H | Dir, 10% | — | $2.62M |
| Driscoll Michael Joseph | Dir | $26.7K | — |
| Leibowitz Arthur S | Dir | $13.4K | — |
| Lustig Garrett | Dir | — | — |
| Cavorsi Robert | VP, Strategy | — | — |
| Quintero Gilberto | Dir | — | — |
| Francisco David | CFO | — | — |
| Duraibabu Prathyusha | Dir | — | — |
| Korfin Michele Ilene | Dir | — | — |
| Montecalvo Antonio S. | VP, Health Policy | — | — |
Transactions 214
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-04-03 | 2024-04-01 | ORGO | Gillheeney Gary S. | Pres, CEO, Dir | F - Tax | $2.80 | -10.1K | 2.35M | -0.4% | -$28.3K | |
| 2024-04-03 | 2024-04-01 | ORGO | Grow Brian | Chief Commercial Off | F - Tax | $2.80 | -1,977 | 520.8K | -0.4% | -$5,536 | |
| D | 2024-03-29 | 2024-03-28 | ORGO | Bilbo Patrick | COO | M - OptEx | $1.18 | +152.2K | 811.6K | +23% | +$179.7K |
| D | 2024-02-23 | 2024-02-21 | ORGO | Bilbo Patrick | COO | A - Grant | $0.00 | +187.3K | 659.3K | +40% | $0 |
| 2024-02-23 | 2024-02-21 | ORGO | Duraibabu Prathyusha | Dir | A - Grant | $0.00 | +51.0K | 148.6K | +52% | $0 | |
| 2024-02-23 | 2024-02-21 | ORGO | Driscoll Michael Joseph | Dir | A - Grant | $0.00 | +51.0K | 142.3K | +56% | $0 | |
| 2024-02-23 | 2024-02-21 | ORGO | Quintero Gilberto | Dir | A - Grant | $0.00 | +51.0K | 140.7K | +57% | $0 | |
| D | 2024-02-23 | 2024-02-21 | ORGO | Grow Brian | Chief Commercial Off | A - Grant | $0.00 | +173.5K | 522.8K | +50% | $0 |
| D | 2024-02-23 | 2024-02-21 | ORGO | Montecalvo Antonio S. | VP, Health Policy | A - Grant | $0.00 | +43.7K | 170.0K | +35% | $0 |
| 2024-02-23 | 2024-02-21 | ORGO | Giacomin Jon L | Dir | A - Grant | $0.00 | +51.0K | 142.6K | +56% | $0 | |
| D | 2024-02-23 | 2024-02-21 | ORGO | Freedman Lori | Chief Admin, Legal Off | A - Grant | $0.00 | +153.1K | 471.2K | +48% | $0 |
| D | 2024-02-23 | 2024-02-21 | ORGO | Gillheeney Gary S. | Pres, CEO, Dir | A - Grant | $0.00 | +685.1K | 2.36M | +41% | $0 |
| 2024-02-23 | 2024-02-21 | ORGO | Korfin Michele Ilene | Dir | A - Grant | $0.00 | +51.0K | 140.7K | +57% | $0 | |
| 2024-02-23 | 2024-02-21 | ORGO | Leibowitz Arthur S | Dir | A - Grant | $0.00 | +51.0K | 187.6K | +37% | $0 | |
| D | 2024-02-23 | 2024-02-21 | ORGO | Francisco David | CFO | A - Grant | $0.00 | +160.3K | 429.0K | +60% | $0 |
| M | 2024-02-20 | 2024-02-15+ | ORGO | Francisco David | CFO | F - Tax | $3.67 | -23.3K | 268.6K | -8% | -$85.5K |
| M | 2024-02-20 | 2024-02-15+ | ORGO | Gillheeney Gary S. | Pres, CEO, Dir | F - Tax | $3.67 | -91.0K | 1.68M | -5% | -$334.1K |
| M | 2024-02-20 | 2024-02-15+ | ORGO | Montecalvo Antonio S. | VP, Health Policy | F - Tax | $3.67 | -10.6K | 127.0K | -8% | -$39.0K |
| M | 2024-02-20 | 2024-02-15+ | ORGO | Bilbo Patrick | COO | F - Tax | $3.67 | -30.3K | 477.4K | -6% | -$111.4K |
| M | 2024-02-20 | 2024-02-15+ | ORGO | Freedman Lori | Chief Admin, Legal Off | F - Tax | $3.67 | -25.8K | 318.8K | -7% | -$94.8K |
| M | 2024-02-20 | 2024-02-15+ | ORGO | Grow Brian | Chief Commercial Off | F - Tax | $3.67 | -22.9K | 350.1K | -6% | -$84.0K |
| M | 2024-01-11 | 2024-01-09+ | ORGO | GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016 | 10% | S - Sale | $4.36 | -215.9K | 59.01M | -0.4% | -$941.8K |
| M | 2024-01-11 | 2024-01-09+ | ORGO | Dennis Erani 2012 Issue Trust dated 12/20/12 | 10% | S - Sale | $4.36 | -215.9K | 59.03M | -0.4% | -$941.8K |
| 2023-04-14 | 2023-04-12 | ORGO | RED Holdings, LLC | 10% | S - Sale | $2.07 | -25.0K | 59.22M | -0.0% | -$51.7K | |
| 2023-04-14 | 2023-04-12 | ORGO | GN 2016 Family Trust u/a/d August 12, 2016 | 10% | S - Sale | $2.07 | -25.0K | 59.22M | -0.0% | -$51.7K | |
| 2023-04-04 | 2023-04-01 | ORGO | Gillheeney Gary S. | Pres, CEO, Dir | F - Tax | $2.13 | -6,470 | 1.77M | -0.4% | -$13.8K | |
| 2023-04-04 | 2023-04-01 | ORGO | Freedman Lori | Chief Admin, Legal Off | F - Tax | $2.13 | -2,339 | 344.0K | -0.7% | -$4,982 | |
| 2023-04-04 | 2023-04-01 | ORGO | Bilbo Patrick | COO | F - Tax | $2.13 | -2,678 | 502.3K | -0.5% | -$5,704 | |
| 2023-04-04 | 2023-04-01 | ORGO | Grow Brian | Chief Commercial Off | F - Tax | $2.13 | -2,408 | 372.2K | -0.6% | -$5,129 | |
| 2023-04-04 | 2023-04-01 | ORGO | Montecalvo Antonio S. | VP, Health Policy | F - Tax | $2.13 | -2,097 | 136.9K | -2% | -$4,467 | |
| D | 2023-02-24 | 2023-02-22 | ORGO | Bilbo Patrick | COO | A - Grant | $0.00 | +327.4K | 505.0K | +184% | $0 |
| D | 2023-02-24 | 2023-02-22 | ORGO | Grow Brian | Chief Commercial Off | A - Grant | $0.00 | +291.0K | 374.6K | +348% | $0 |
| D | 2023-02-24 | 2023-02-22 | ORGO | Francisco David | CFO | A - Grant | $0.00 | +242.5K | 291.9K | +491% | $0 |
| D | 2023-02-24 | 2023-02-22 | ORGO | Montecalvo Antonio S. | VP, Health Policy | A - Grant | $0.00 | +99.4K | 139.0K | +251% | $0 |
| 2023-02-24 | 2023-02-22 | ORGO | Korfin Michele Ilene | Dir | A - Grant | $0.00 | +65.7K | 89.7K | +275% | $0 | |
| 2023-02-24 | 2023-02-22 | ORGO | Driscoll Michael Joseph | Dir | A - Grant | $0.00 | +65.7K | 91.3K | +257% | $0 | |
| 2023-02-24 | 2023-02-22 | ORGO | Giacomin Jon L | Dir | A - Grant | $0.00 | +65.7K | 91.6K | +254% | $0 | |
| 2023-02-24 | 2023-02-22 | ORGO | Leibowitz Arthur S | Dir | A - Grant | $0.00 | +65.7K | 136.6K | +93% | $0 | |
| D | 2023-02-24 | 2023-02-22 | ORGO | Gillheeney Gary S. | Pres, CEO, Dir | A - Grant | $0.00 | +896.4K | 1.77M | +102% | $0 |
| 2023-02-24 | 2023-02-22 | ORGO | Quintero Gilberto | Dir | A - Grant | $0.00 | +65.7K | 89.7K | +275% | $0 | |
| 2023-02-24 | 2023-02-22 | ORGO | Duraibabu Prathyusha | Dir | A - Grant | $0.00 | +65.7K | 97.6K | +206% | $0 | |
| D | 2023-02-24 | 2023-02-22 | ORGO | Freedman Lori | VP, GC | A - Grant | $0.00 | +278.9K | 346.3K | +413% | $0 |
| M | 2023-02-17 | 2023-02-15+ | ORGO | Freedman Lori | VP, GC | F - Tax | $2.89 | -4,400 | 67.4K | -6% | -$12.7K |
| M | 2023-02-17 | 2023-02-15+ | ORGO | Francisco David | CFO | F - Tax | $2.88 | -4,459 | 50.4K | -8% | -$12.9K |
| M | 2023-02-17 | 2023-02-15+ | ORGO | Gillheeney Gary S. | Pres, CEO, Dir | F - Tax | $2.89 | -25.3K | 881.8K | -3% | -$73.2K |
| M | 2023-02-17 | 2023-02-15+ | ORGO | Bilbo Patrick | COO | F - Tax | $2.89 | -5,535 | 177.6K | -3% | -$16.0K |
| M | 2023-02-17 | 2023-02-15+ | ORGO | Grow Brian | Chief Commercial Off | F - Tax | $2.89 | -4,145 | 83.6K | -5% | -$12.0K |
| M | 2023-02-17 | 2023-02-15+ | ORGO | Montecalvo Antonio S. | VP Health Policy, Contracting | F - Tax | $2.86 | -1,966 | 39.6K | -5% | -$5,619 |
| M | 2022-11-22 | 2022-11-18+ | ORGO | KATZ MICHAEL W | 10% | P - Purchase | $2.56 | +6,000 | 73.4K | +9% | +$15.4K |
| D | 2022-08-24 | 2022-08-20 | ORGO | Grow Brian | Chief Commercial Off | M - OptEx | $1.46 | +805 | 87.7K | +0.9% | +$1,175 |
| 2022-08-15 | 2022-08-12 | ORGO | Leibowitz Arthur S | Dir | P - Purchase | $4.76 | +3,000 | 70.9K | +4% | +$14.3K | |
| 2022-08-15 | 2022-08-12 | ORGO | Driscoll Michael Joseph | Dir | P - Purchase | $4.80 | +5,000 | 25.5K | +24% | +$24.0K | |
| D | 2022-07-01 | 2022-06-30 | ORGO | Gillheeney Gary S. | Pres, CEO, Dir | M - OptEx | $0.99 | +505.1K | 903.3K | +127% | +$500.0K |
| M | 2022-06-13 | 2022-06-09+ | ORGO | Dennis Erani 2012 Issue Trust dated 12/20/12 | 10% | S - Sale | $4.89 | -30.0K | 59.25M | -0.1% | -$146.8K |
| M | 2022-06-13 | 2022-06-09+ | ORGO | RED Holdings, LLC | 10% | S - Sale | $4.89 | -30.0K | 59.25M | -0.1% | -$146.8K |
| M | 2022-06-08 | 2022-06-06+ | ORGO | RED Holdings, LLC | 10% | S - Sale | $5.43 | -170.0K | 59.35M | -0.3% | -$923.3K |
| M | 2022-06-08 | 2022-06-06+ | ORGO | Albert Erani Family Trust dated 12/29/2012 | 10% | S - Sale | $5.43 | -170.0K | 59.30M | -0.3% | -$923.3K |
| DM | 2022-06-03 | 2022-06-01+ | ORGO | Gillheeney Gary S. | Pres, CEO, Dir | M - OptEx | $0.99 | +247.3K | 514.9K | +92% | +$244.9K |
| DM | 2022-06-03 | 2022-06-01+ | ORGO | Gillheeney Gary S. | Pres, CEO, Dir | S - Sale+OE | $5.55 | -247.3K | 398.2K | -38% | -$1.37M |
| DM | 2022-05-31 | 2022-05-26+ | ORGO | Gillheeney Gary S. | Pres, CEO, Dir | S - Sale+OE | $5.75 | -226.8K | 398.2K | -36% | -$1.30M |
| DM | 2022-05-31 | 2022-05-26+ | ORGO | Gillheeney Gary S. | Pres, CEO, Dir | M - OptEx | $0.99 | +226.8K | 459.4K | +97% | +$224.5K |
| DM | 2022-05-25 | 2022-05-23+ | ORGO | Gillheeney Gary S. | Pres, CEO, Dir | S - Sale+OE | $5.68 | -197.3K | 451.9K | -30% | -$1.12M |
| DM | 2022-05-25 | 2022-05-23+ | ORGO | Gillheeney Gary S. | Pres, CEO, Dir | M - OptEx | $0.99 | +197.3K | 450.6K | +78% | +$195.4K |
| DM | 2022-05-20 | 2022-05-18+ | ORGO | Gillheeney Gary S. | Pres, CEO, Dir | S - Sale+OE | $5.77 | -263.7K | 398.2K | -40% | -$1.52M |
| DM | 2022-05-20 | 2022-05-18+ | ORGO | Gillheeney Gary S. | Pres, CEO, Dir | M - OptEx | $0.99 | +263.7K | 456.9K | +136% | +$261.1K |
| M | 2022-05-18 | 2022-05-16 | ORGO | KATZ MICHAEL W | 10% | P - Purchase | $6.03 | +10.0K | 67.4K | +17% | +$60.3K |
| DM | 2022-05-17 | 2022-05-13+ | ORGO | Gillheeney Gary S. | Pres, CEO, Dir | M - OptEx | $0.99 | +314.8K | 496.3K | +173% | +$311.7K |
| DM | 2022-05-17 | 2022-05-13+ | ORGO | Gillheeney Gary S. | Pres, CEO, Dir | S - Sale+OE | $6.02 | -314.8K | 398.2K | -44% | -$1.90M |
| 2022-05-05 | 2022-05-03 | ORGO | Korfin Michele Ilene | Dir | A - Grant | $0.00 | +23.9K | 23.9K | New | $0 | |
| 2022-05-05 | 2022-05-03 | ORGO | Quintero Gilberto | Dir | A - Grant | $0.00 | +23.9K | 23.9K | New | $0 | |
| 2022-04-05 | 2022-04-01 | ORGO | Gillheeney Gary S. | Pres, CEO, Dir | F - Tax | $7.89 | -9,789 | 398.2K | -2% | -$77.2K | |
| 2022-04-05 | 2022-04-01 | ORGO | Montecalvo Antonio S. | VP, Health Policy | F - Tax | $7.89 | -2,738 | 41.6K | -6% | -$21.6K | |
| 2022-04-05 | 2022-04-01 | ORGO | Freedman Lori | VP, GC | F - Tax | $7.89 | -2,984 | 71.8K | -4% | -$23.5K | |
| 2022-04-05 | 2022-04-01 | ORGO | Bilbo Patrick | COO | F - Tax | $7.89 | -2,497 | 183.2K | -1% | -$19.7K | |
| 2022-04-05 | 2022-04-01 | ORGO | Grow Brian | Chief Commercial Off | F - Tax | $7.89 | -1,977 | 86.9K | -2% | -$15.6K | |
| DM | 2022-03-11 | 2022-03-10 | ORGO | Montecalvo Antonio S. | VP, Health Policy | M - OptEx | $3.46 | +68.5K | 141.7K | +94% | +$237.0K |
| DM | 2022-03-11 | 2022-03-09+ | ORGO | Montecalvo Antonio S. | VP, Health Policy | S - Sale+OE | $8.40 | -107.4K | 73.2K | -59% | -$902.7K |
| D | 2022-02-17 | 2022-02-16 | ORGO | Freedman Lori | VP, GC | F - Tax | $7.78 | -765 | 74.8K | -1% | -$5,952 |
| D | 2022-02-17 | 2022-02-15 | ORGO | Freedman Lori | VP, GC | A - Grant | $0.00 | +41.8K | 75.6K | +124% | $0 |
| D | 2022-02-17 | 2022-02-16 | ORGO | Montecalvo Antonio S. | VP Health Policy, Contracting | F - Tax | $7.78 | -718 | 83.2K | -0.9% | -$5,586 |
| D | 2022-02-17 | 2022-02-15 | ORGO | Montecalvo Antonio S. | VP Health Policy, Contracting | A - Grant | $0.00 | +14.4K | 83.9K | +21% | $0 |
| D | 2022-02-17 | 2022-02-15 | ORGO | Gillheeney Gary S. | Pres, CEO, Dir | A - Grant | $0.00 | +280.2K | 412.1K | +212% | $0 |
| D | 2022-02-17 | 2022-02-16 | ORGO | Gillheeney Gary S. | Pres, CEO, Dir | F - Tax | $7.78 | -4,085 | 408.0K | -1.0% | -$31.8K |
| 2022-02-17 | 2022-02-15 | ORGO | Driscoll Michael Joseph | Dir | A - Grant | $0.00 | +20.5K | 20.5K | New | $0 | |
| D | 2022-02-17 | 2022-02-16 | ORGO | Bilbo Patrick | COO | F - Tax | $7.78 | -937 | 185.7K | -0.5% | -$7,290 |
| D | 2022-02-17 | 2022-02-15 | ORGO | Bilbo Patrick | COO | A - Grant | $0.00 | +52.9K | 186.6K | +40% | $0 |
| DM | 2022-02-17 | 2022-02-15+ | ORGO | Francisco David | CFO | F - Tax | $7.95 | -2,829 | 53.9K | -5% | -$22.5K |
| D | 2022-02-17 | 2022-02-15 | ORGO | Francisco David | CFO | A - Grant | $0.00 | +40.3K | 56.7K | +247% | $0 |
| 2022-02-17 | 2022-02-15 | ORGO | Duraibabu Prathyusha | Dir | A - Grant | $0.00 | +20.5K | 31.9K | +181% | $0 | |
| 2022-02-17 | 2022-02-15 | ORGO | Giacomin Jon L | Dir | A - Grant | $0.00 | +20.5K | 25.9K | +386% | $0 | |
| D | 2022-02-17 | 2022-02-16 | ORGO | Grow Brian | Chief Commercial Off | F - Tax | $7.78 | -799 | 88.9K | -0.9% | -$6,216 |
| D | 2022-02-17 | 2022-02-15 | ORGO | Grow Brian | Chief Commercial Off | A - Grant | $0.00 | +45.1K | 89.7K | +101% | $0 |
| 2022-02-17 | 2022-02-15 | ORGO | Leibowitz Arthur S | Dir | A - Grant | $0.00 | +20.5K | 67.9K | +43% | $0 | |
| M | 2021-12-30 | 2021-12-28 | ORGO | Erani Dennis | 10% | G - Gift | $0.00 | +4.66M | 59.45M | +9% | $0 |
| I | 2021-12-30 | 2021-12-28 | ORGO | Erani Dennis | 10% | G - Gift | $0.00 | -4.66M | 59.45M | -7% | $0 |
| I | 2021-12-30 | 2021-12-28 | ORGO | Organo Investors LLC | 10% | G - Gift | $0.00 | -4.66M | 59.45M | -7% | $0 |
| M | 2021-12-30 | 2021-12-28 | ORGO | Organo Investors LLC | 10% | G - Gift | $0.00 | +4.66M | 59.45M | +9% | $0 |
| 2021-12-17 | 2021-12-15 | ORGO | Alan Ades 2014 GRAT | 10% | G - Gift | $0.00 | +5.42M | 59.45M | +10% | $0 | |
| I | 2021-12-17 | 2021-12-15 | ORGO | Alan Ades 2014 GRAT | 10% | G - Gift | $0.00 | -5.42M | 59.45M | -8% | $0 |
| 2021-12-17 | 2021-12-15 | ORGO | Erani Dennis | 10% | G - Gift | $0.00 | +5.42M | 59.45M | +10% | $0 |
Purchase Sale Sale after option exercise All abbreviations